Pad4fl/fl floxed mice may be useful for studying the formation of neutrophil extracellular traps during acute infection.
Kerri Mowen, The Scripps Research Institute
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed)) | Padi4 | peptidyl arginine deiminase, type IV |
Pad4fl/fl floxed mice possess loxP sites flanking exons 9-10 of the peptidyl arginine deiminase, type IV (Padi4) gene. These exons contain part of the PAD4 active site, as well as four additional residues that are essential for Ca2+ binding. PAD4 is an enzyme responsible for the citrullination and deimination conversion of arginine to citrulline residues on histones. PAD4-mediated deimination of histone H3 and H4 is required for the formation of neutrophil extracellular traps (NETs), specialized anti-microbial structures comprised of decondensed chromatin decorated with microbicidal agents. NETs are responsible for killing gram-positive and gram-negative bacteria as well as fungi. Increased amounts of NETs are detrimental in chronic neutrophil-mediated inflammation such as the lung diseases chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) due to increased severity of lung obstruction. Homozygous mice are viable and fertile. When bred to mice that express tissue-specific Cre recombinase, resulting offspring will have exons 9-10 deleted in the cre-expressing tissues.
When bred to B6.C-Tg(CMV-cre)1Cgn/J mice (Stock No. 006054) with widespread Cre recombinase expression, histone deimination is absent in neutrophils of resulting offspring, and they are defective in NET formation. PAD4 KO mice lose significantly more weight during influenza A infection, but retain normal survival. The number of lung infiltrating leukocytes was similar to that seen in wildtype mice during infection.
A targeting vector was designed by Dr. Kerri Mowen (The Scripps Research Institute) to insert a loxP site followed by a frt-flanked neomycin resistance (neo) cassette upstream of exon 9, and a second loxP site downstream of exon 10 of the peptidyl arginine deiminase, type IV (Padi4) gene. The construct was electroporated into B6.Cg-Thy1a-derived Bruce 4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into B6(Cg)-Tyrc-2J/J albino blastocysts and resulting chimeric males were bred with B6(Cg)-Tyrc-2J/J albino females (Stock No. 000058). Offspring were bred with B6.Cg-Tg(ACTFLPe)9205Dym/J transgenic mice (Stock No. 005703) to delete the neo cassette, and progeny were crossed to remove the Flp-expressing transgene. Pad4fl/fl mice were bred to C57BL/6J mice for at least 3 generations. Upon arrival, sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize C57BL/6J oocytes (Stock No. 000664). The Tyrc-2J allele was not maintained in the colony.
Allele Name | targeted mutation 1.2, Kerri A Mowen |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed)) |
Allele Synonym(s) | Padi4fl |
Gene Symbol and Name | Padi4, peptidyl arginine deiminase, type IV |
Gene Synonym(s) | |
Strain of Origin | B6.Cg-Thy1a |
Chromosome | 4 |
Molecular Note | A targeting vector was designed to insert a loxP site followed by an FRT-flanked neomycin resistance (neo) cassette upstream of exon 9, and a second loxP site downstream of exon 10. Flp-mediated recombination removed the FRT-flanked neo cassette leaving exons 9 through 10 floxed. |
When maintaining a live colony, homozygous mice may be bred together.
When using the Pad4 flox mouse strain in a publication, please cite the originating article(s) and include JAX stock #026708 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Padi4<tm1.2Kmow> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.